The future level of global spending on medicines has implications for healthcare systems and policymakers across developed and emerging economies, and these issues are even more important in light of the ongoing global COVID-19 pandemic. Stakeholders share common goals of improving health outcomes while controlling costs and expanding access to medicines, however these tasks have been made more challenging by uncertainties brought on by the pandemic. Past spending growth typically offers some clues on expected future growth and, broadly, that will still be true despite the unprecedented dynamics at play. This report examines trends in medicine spending along with factors influencing growth, including patent expiries, launches of new medicines, and changes in demand and use, particularly in pharmerging and lower income countries.
The global medicine market — using invoice price levels — is expected to grow at 3–6% CAGR through 2025, reaching about $1.6 trillion in total market size in 2025. This excludes spending on COVID-19 vaccines, where total cumulative spending through 2025 is projected to be $157 billion. In this report, we quantify the impact of dynamics influencing growth in the use of medicines and examine current levels of spending and use in 2020, globally, and for specific therapy areas and countries.
In developed countries, the adoption of new treatments, offset by patent lifecycles and competition from generics and biosimilars, are expected to continue as the main factors influencing medicine spending and growth. New brands in the region are projected to continue a historically high period of spending on novel medicines through 2025, similar in absolute spending to the past five years.
In pharmerging countries, dramatic increases in healthcare access were the largest driver of changes in the use of medicines historically, but the trend is slowing and will result in volume declines across many markets. Growth in the region will be led by China, which is expected to accelerate, post-COVID, driven by greater uptake and use of new original medicines.
Exhibit 9: Comparison of Current Outlook to Pre-COVID-19 Outlook
Exhibit 10: Historical and Projected Use of Medicine by Segment, 2010-2025, Defined Daily Doses (DDD) in Billions
Exhibit 17: Global Medicine Market Size and Growth 2010-2025, Cons US$Bn
Exhibit 33: Global Historic and Forecast Spending Growth for Top 20 Therapy Areas